SCHEMBL2403571

SCHEMBL2403571

CC(=O)Oc1cccc(C(N)=O)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 6/20 0.68
LMNA P02545 2/20 0.59
CYP3A4 P08684 1/20 0.59
TNKS O95271 1/20 0.59
PARP15 Q460N3 1/20 0.59
PARP14 Q460N5 1/20 0.59
PARP10 Q53GL7 1/20 0.59
TNKS2 Q9H2K2 1/20 0.59
PARP2 Q9UGN5 1/20 0.59
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
ACHE P22303 1/20 0.54
NPC1 O15118 1/20 0.54
ALDH1A1 P00352 1/20 0.54
TP53 P04637 1/20 0.54
HTT P42858 1/20 0.54
RAB9A P51151 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
CTSL P07711 1/20 0.52
CTSB P07858 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29484325 0.86 CTSL (0.56) PARP1LMNACYP3A4TNKSPARP15
SCHEMBL18155132 0.86 CTSL (0.56) PARP1LMNACYP3A4TNKSPARP15
SCHEMBL201369 0.85 MAOB (0.58) PARP1PARP15PARP14PARP10
SCHEMBL30239922 0.85 LMNA (0.63) LMNACYP3A4MEN1KMT2AACHE
SCHEMBL28870970 0.85 MEN1 (0.73) PARP1CYP3A4TNKSPARP15PARP14
SCHEMBL3141164 0.85 LMNA (0.63) LMNACYP3A4MEN1KMT2AACHE
SCHEMBL16952895 0.85 LMNA (0.63) PARP1LMNACYP3A4MEN1KMT2A
Hydrazine SCHEMBL8166461 0.84 LMNA (0.64) LMNACYP3A4MEN1KMT2AACHE
SCHEMBL258461 0.83 LMNA (0.68) LMNACYP3A4MEN1KMT2AACHE
SCHEMBL29492631 0.83 LMNA (0.68) LMNACYP3A4MEN1KMT2AACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8017628-B2 Pharmaceutically active sulfonyl hydrazide derivatives MERCK SERONO S.A. (CH) 2011-09-13 US disclosed
WO-2010028776-A1 PIPERAZINE DERIVATIVES FOR BINDING AND IMAGING AMYLOID PLAQUES AND THEIR USE BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-03-18 WO disclosed
US-20090005426-A1 PHARMACEUTICALLY ACTIVE SULFONYL HYDRAZIDE DERIVATIVES LABORATOIRES SERONO S.A. (CH) 2009-01-01 US disclosed
US-7432286-B1 Pharmaceutically active sulfonyl hydrazide derivatives LABORATORIES SERONO SA (CH) 2008-10-07 US disclosed
EP-1216245-B1 PHARMACEUTICALLY ACTIVE SULFONYL HYDRAZIDE DERIVATIVES APPLIED RESEARCH SYSTEMS (AN) 2004-05-26 EP disclosed
EP-1216245-A1 PHARMACEUTICALLY ACTIVE SULFONYL HYDRAZIDE DERIVATIVES Applied Research Systems ARS Holding N.V. (AN) 2002-06-26 EP disclosed
WO-2001023382-A1 PHARMACEUTICALLY ACTIVE SULFONYL HYDRAZIDE DERIVATIVES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2001-04-05 WO disclosed
EP-1088822-A1 Pharmaceutically active sulfonyl hydrazide derivatives Applied Research Systems ARS Holding N.V. (AN) 2001-04-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005426-A1 PHARMACEUTICALLY ACTIVE SULFONYL HYDRAZIDE DERIVATIVES SLC5A1, SLC5A2, IAPP PARP1 3416/4885LMNA 3499/4885CYP3A4 1486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.